MA45779A - Polypeptides immunomdulateurs et compositions et procédés associés - Google Patents
Polypeptides immunomdulateurs et compositions et procédés associésInfo
- Publication number
- MA45779A MA45779A MA045779A MA45779A MA45779A MA 45779 A MA45779 A MA 45779A MA 045779 A MA045779 A MA 045779A MA 45779 A MA45779 A MA 45779A MA 45779 A MA45779 A MA 45779A
- Authority
- MA
- Morocco
- Prior art keywords
- immunomdulators
- polypeptides
- processes
- related compositions
- compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/521—Chemokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
- C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57554—Prolactin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormones [GH] (Somatotropin)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/7051—T-cell receptor (TcR)-CD3 complex
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662369017P | 2016-07-29 | 2016-07-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA45779A true MA45779A (fr) | 2019-06-05 |
Family
ID=59631857
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA045779A MA45779A (fr) | 2016-07-29 | 2017-07-28 | Polypeptides immunomdulateurs et compositions et procédés associés |
Country Status (10)
Country | Link |
---|---|
US (1) | US20190194283A1 (fr) |
EP (1) | EP3490585B1 (fr) |
JP (2) | JP7295795B2 (fr) |
CN (1) | CN110087672A (fr) |
AU (1) | AU2017301880C1 (fr) |
CA (1) | CA3031955A1 (fr) |
ES (1) | ES2951552T3 (fr) |
MA (1) | MA45779A (fr) |
MX (1) | MX2019001185A (fr) |
WO (1) | WO2018023093A1 (fr) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3443001A4 (fr) | 2016-04-11 | 2020-04-29 | Obsidian Therapeutics, Inc. | Systèmes de biocircuits régulés |
AU2018297248A1 (en) | 2017-07-03 | 2020-02-20 | Torque Therapeutics, Inc. | Fusion molecules targeting immune regulatory cells and uses thereof |
CN112088165A (zh) * | 2018-03-14 | 2020-12-15 | 西雅图儿童医院(Dba西雅图儿童研究所) | 靶向IL-13受体α2的、zetakine定向的T细胞免疫疗法 |
AU2019271149B2 (en) * | 2018-05-14 | 2023-07-13 | Werewolf Therapeutics, Inc. | Activatable interleukin 12 polypeptides and methods of use thereof |
EP3802615A4 (fr) | 2018-06-04 | 2022-04-13 | Precigen, Inc. | Récepteurs antigéniques chimériquesspecifiques de muc16 et utilisations associées |
CN109306016B (zh) * | 2018-08-15 | 2021-10-22 | 华东师范大学 | 共表达细胞因子il-7的nkg2d-car-t细胞及其用途 |
JP2021536265A (ja) * | 2018-09-07 | 2021-12-27 | ソティオ,リミティド ライアビリティ カンパニー | 細胞内乳酸濃度を調節するトランス代謝分子と組み合わせたキメラ受容体ポリペプチド及びその治療的使用 |
EP3922721A4 (fr) * | 2019-03-12 | 2023-01-11 | Chongqing Precision Biotech Company Limited | Promoteur régulé par hypoxie et son application |
CN111848811A (zh) * | 2019-04-27 | 2020-10-30 | 张晋宇 | 一种蛋白质异二聚体及其用途 |
WO2020236655A1 (fr) | 2019-05-17 | 2020-11-26 | Xencor, Inc. | Protéines de fusion il-7-fc |
CN112294760A (zh) * | 2019-07-26 | 2021-02-02 | 张晋宇 | 一种液体制剂及其应用 |
WO2021081345A1 (fr) * | 2019-10-25 | 2021-04-29 | Mayo Foundation For Medical Education And Research | Bipeptide ayant une affinité avec des protéines ou des cellules de la matrice extracellulaire et avec des facteurs de croissance permettant la cicatrisation et la régénération de tissus |
WO2021115333A1 (fr) * | 2019-12-10 | 2021-06-17 | 苏州克睿基因生物科技有限公司 | Protéine de fusion et cellule immunitaire modifiée exprimant celle-ci et application de cellule immunitaire modifiée |
CN111153961B (zh) * | 2020-01-08 | 2022-02-18 | 郑州大学 | 一种亲和pd-1的肽及其应用 |
WO2021154455A1 (fr) * | 2020-01-30 | 2021-08-05 | Purdue Research Foundation | Administration médiée par ligand de protéines thérapeutiques et leurs utilisations |
CN111533785B (zh) * | 2020-02-11 | 2022-03-08 | 北京市肿瘤防治研究所 | 靶向免疫检查点tim3结合肽及其应用 |
WO2021163874A1 (fr) * | 2020-02-18 | 2021-08-26 | 苏州工业园区唯可达生物科技有限公司 | Vecteur viral recombinant, composition immunogène le comprenant et utilisations |
CN112063588A (zh) * | 2020-08-13 | 2020-12-11 | 南京北恒生物科技有限公司 | 工程化免疫细胞及其用途 |
CN114249807B (zh) * | 2021-08-13 | 2023-12-05 | 上海鑫湾生物科技有限公司 | 缺氧触发的人工转录因子、转录控制系统及其应用 |
WO2023060047A1 (fr) * | 2021-10-04 | 2023-04-13 | California Institute Of Technology | Commutateurs pour états thermiques dans les macrophages |
US20230151095A1 (en) | 2021-11-12 | 2023-05-18 | Xencor, Inc. | Bispecific antibodies that bind to b7h3 and nkg2d |
WO2023137069A2 (fr) * | 2022-01-12 | 2023-07-20 | St. Jude Children's Research Hospital, Inc. | Récepteurs antigéniques chimériques bispécifiques ciblant grp78 et cd123 ou grp78 et b7h3 |
Family Cites Families (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
US4452773A (en) | 1982-04-05 | 1984-06-05 | Canadian Patents And Development Limited | Magnetic iron-dextran microspheres |
US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
US5019369A (en) | 1984-10-22 | 1991-05-28 | Vestar, Inc. | Method of targeting tumors in humans |
US4690915A (en) | 1985-08-08 | 1987-09-01 | The United States Of America As Represented By The Department Of Health And Human Services | Adoptive immunotherapy as a treatment modality in humans |
US4795698A (en) | 1985-10-04 | 1989-01-03 | Immunicon Corporation | Magnetic-polymer particles |
IN165717B (fr) | 1986-08-07 | 1989-12-23 | Battelle Memorial Institute | |
US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
US5219740A (en) | 1987-02-13 | 1993-06-15 | Fred Hutchinson Cancer Research Center | Retroviral gene transfer into diploid fibroblasts for gene therapy |
ES2067018T3 (es) | 1988-12-28 | 1995-03-16 | Stefan Miltenyi | Procedimiento y materiales para la separacion en alto gradiente magnetico de materiales biologicos. |
US5200084A (en) | 1990-09-26 | 1993-04-06 | Immunicon Corporation | Apparatus and methods for magnetic separation |
DE4228458A1 (de) | 1992-08-27 | 1994-06-01 | Beiersdorf Ag | Multicistronische Expressionseinheiten und deren Verwendung |
US5827642A (en) | 1994-08-31 | 1998-10-27 | Fred Hutchinson Cancer Research Center | Rapid expansion method ("REM") for in vitro propagation of T lymphocytes |
US20020150914A1 (en) | 1995-06-30 | 2002-10-17 | Kobenhavns Universitet | Recombinant antibodies from a phage display library, directed against a peptide-MHC complex |
DE19608753C1 (de) | 1996-03-06 | 1997-06-26 | Medigene Gmbh | Transduktionssystem und seine Verwendung |
WO1997034634A1 (fr) | 1996-03-20 | 1997-09-25 | Sloan-Kettering Institute For Cancer Research | Produits de recombinaison d'anticorps diriges contre le gd2, constitues d'un fragment variable (fv) a chaine simple |
EP1109921A4 (fr) | 1998-09-04 | 2002-08-28 | Sloan Kettering Inst Cancer | Recepteurs de fusion specifiques a l'antigene prostatique specifique membranaire et ses utilisations |
WO2000023573A2 (fr) | 1998-10-20 | 2000-04-27 | City Of Hope | Cellules modifiees specifiques a la molecule cd20 et utilisation de ces dernieres pour l'immunotherapie cellulaires des malignites cd20?+¿ |
ATE316982T1 (de) * | 1999-08-09 | 2006-02-15 | Lexigen Pharm Corp | Mehrere zytokin-antikörper komplexen |
AU2001265346A1 (en) | 2000-06-02 | 2001-12-17 | Memorial Sloan-Kettering Cancer Center | Artificial antigen presenting cells and methods of use thereof |
EP1334188B1 (fr) | 2000-11-07 | 2006-08-30 | City of Hope | Cellules immunitaires specifiques a cd19 redirigees |
US7070995B2 (en) | 2001-04-11 | 2006-07-04 | City Of Hope | CE7-specific redirected immune cells |
US20090257994A1 (en) | 2001-04-30 | 2009-10-15 | City Of Hope | Chimeric immunoreceptor useful in treating human cancers |
US7939059B2 (en) | 2001-12-10 | 2011-05-10 | California Institute Of Technology | Method for the generation of antigen-specific lymphocytes |
US20030170238A1 (en) | 2002-03-07 | 2003-09-11 | Gruenberg Micheal L. | Re-activated T-cells for adoptive immunotherapy |
US7446190B2 (en) | 2002-05-28 | 2008-11-04 | Sloan-Kettering Institute For Cancer Research | Nucleic acids encoding chimeric T cell receptors |
EP1418184A1 (fr) * | 2002-11-08 | 2004-05-12 | Cell Center Cologne GmbH | Protéine recombinante comprenant les subunités p40 et p35 de IL-12 et un scFv et leur utilisation |
US20050129671A1 (en) | 2003-03-11 | 2005-06-16 | City Of Hope | Mammalian antigen-presenting T cells and bi-specific T cells |
WO2008136869A2 (fr) | 2006-12-06 | 2008-11-13 | Burnham Institute For Medical Research | Procédés et compositions relatives au ciblage de lésions, de tissu de régénération et de tumeurs |
US8536113B2 (en) * | 2006-12-21 | 2013-09-17 | Janssen Biotech, Inc. | EGFR binding peptides and uses thereof |
EP2141997B1 (fr) | 2007-03-30 | 2012-10-31 | Memorial Sloan-Kettering Cancer Center | Expression constitutive de ligands costimulants sur des lymphocytes t transférés de manière adoptive |
EP3338896A1 (fr) | 2007-12-07 | 2018-06-27 | Miltenyi Biotec GmbH | Systèmes et procédés de traitement d'échantillons |
US8479118B2 (en) | 2007-12-10 | 2013-07-02 | Microsoft Corporation | Switching search providers within a browser search box |
US20120164718A1 (en) | 2008-05-06 | 2012-06-28 | Innovative Micro Technology | Removable/disposable apparatus for MEMS particle sorting device |
JP5173594B2 (ja) | 2008-05-27 | 2013-04-03 | キヤノン株式会社 | 管理装置、画像形成装置及びそれらの処理方法 |
US8617557B2 (en) * | 2010-03-12 | 2013-12-31 | The Regents Of The University Of California | Antibody fusion with IL-12 proteins with disrupted heparin-binding activity |
JP5947311B2 (ja) | 2010-12-09 | 2016-07-06 | ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア | 癌を治療するためのキメラ抗原受容体改変t細胞の使用 |
AU2012230780B2 (en) | 2011-03-23 | 2016-10-27 | Fred Hutchinson Cancer Center | Method and compositions for cellular immunotherapy |
JP6082997B2 (ja) | 2011-04-01 | 2017-02-22 | メモリアル スローン−ケタリング キャンサー センター | Hla−a2により提示されるwt1ペプチドへのt細胞受容体様抗体 |
US8398282B2 (en) | 2011-05-12 | 2013-03-19 | Delphi Technologies, Inc. | Vehicle front lighting assembly and systems having a variable tint electrowetting element |
JP6368243B2 (ja) | 2011-11-11 | 2018-08-08 | フレッド ハッチンソン キャンサー リサーチ センター | がんのためのサイクリンa1に標的化されたt細胞免疫療法 |
CA2861491C (fr) | 2012-02-13 | 2020-08-25 | Seattle Children's Hospital D/B/A Seattle Children's Research Institute | Recepteurs d'antigene chimeres bispecifiques et utilisations therapeutiques de ceux-ci |
WO2013126726A1 (fr) | 2012-02-22 | 2013-08-29 | The Trustees Of The University Of Pennsylvania | Lymphocytes t doubles transgéniques comportant un car et un tcr, et leurs procédés d'utilisation |
CA2872471C (fr) | 2012-05-03 | 2022-11-22 | Fred Hutchinson Cancer Research Center | Recepteurs de lymphocyte t a affinite augmentee et procedes pour fabriquer ceux-ci |
KR102135239B1 (ko) | 2012-08-20 | 2020-07-17 | 프레드 헛친슨 켄서 리서치 센터 | 세포 면역요법을 위한 방법 및 조성물 |
ES2743738T3 (es) | 2012-10-02 | 2020-02-20 | Memorial Sloan Kettering Cancer Center | Composiciones y métodos para inmunoterapia |
DE112012007250T5 (de) | 2012-12-20 | 2015-10-08 | Mitsubishi Electric Corp. | Fahrzeuginterne Vorrichtung und Programm |
EP2961831B1 (fr) | 2013-02-26 | 2020-06-10 | Memorial Sloan Kettering Cancer Center | Compositions et procédés d'immunothérapie |
WO2014139468A1 (fr) * | 2013-03-15 | 2014-09-18 | Admark Healthcare, Llc | Molécules de protéine de fusion et leur procédé d'utilisation |
AU2014262469B2 (en) * | 2013-05-10 | 2019-11-14 | Whitehead Institute For Biomedical Research | Protein modification of living cells using sortase |
US9108442B2 (en) | 2013-08-20 | 2015-08-18 | Ricoh Company, Ltd. | Image forming apparatus |
-
2017
- 2017-07-28 CN CN201780058404.8A patent/CN110087672A/zh active Pending
- 2017-07-28 EP EP17752521.9A patent/EP3490585B1/fr active Active
- 2017-07-28 US US16/320,075 patent/US20190194283A1/en active Pending
- 2017-07-28 AU AU2017301880A patent/AU2017301880C1/en active Active
- 2017-07-28 CA CA3031955A patent/CA3031955A1/fr active Pending
- 2017-07-28 WO PCT/US2017/044549 patent/WO2018023093A1/fr unknown
- 2017-07-28 ES ES17752521T patent/ES2951552T3/es active Active
- 2017-07-28 MA MA045779A patent/MA45779A/fr unknown
- 2017-07-28 MX MX2019001185A patent/MX2019001185A/es unknown
- 2017-07-28 JP JP2019504812A patent/JP7295795B2/ja active Active
-
2023
- 2023-02-20 JP JP2023024001A patent/JP2023062104A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2019531704A (ja) | 2019-11-07 |
CN110087672A (zh) | 2019-08-02 |
WO2018023093A1 (fr) | 2018-02-01 |
US20190194283A1 (en) | 2019-06-27 |
CA3031955A1 (fr) | 2018-02-01 |
AU2017301880C1 (en) | 2022-04-21 |
AU2017301880B2 (en) | 2021-11-04 |
ES2951552T3 (es) | 2023-10-23 |
MX2019001185A (es) | 2019-10-21 |
AU2017301880A1 (en) | 2019-02-07 |
JP7295795B2 (ja) | 2023-06-21 |
EP3490585B1 (fr) | 2023-05-17 |
JP2023062104A (ja) | 2023-05-02 |
EP3490585A1 (fr) | 2019-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA45779A (fr) | Polypeptides immunomdulateurs et compositions et procédés associés | |
MA43380A (fr) | Récepteurs chimériques modifiés et compositions et procédés associés | |
DK3443009T3 (da) | Anti-tim-3-antistoffer og sammensætninger | |
MA46458A (fr) | Compositions debacillus thuringiensis | |
DK3303379T3 (da) | Tigit-bindende midler og anvendelser deraf | |
DK3495023T3 (da) | Semifluorerede forbindelser og sammensætninger deraf | |
DK3268470T3 (da) | Transposasepolypeptider og anvendelser deraf | |
SI3347472T1 (sl) | Sestavki, ki obsegajo polipeptide klada CYP76AD1, in uporabe le-teh | |
DK3480213T3 (da) | Syntac-polypeptider og anvendelser deraf | |
DK3302431T3 (da) | Taxanpartikler og anvendelse deraf | |
DK3538864T3 (da) | Mikrotom | |
TWI800019B (zh) | 樹脂組成物 | |
DK3316909T3 (da) | Anti-ntb-a-antistoffer og relaterede sammensætninger og fremgangsmåder | |
DK4089113T3 (da) | Polypeptider | |
DK3018183T3 (da) | Halogenolefinbaseret sammensætning og anvendelse deraf | |
DK3102555T3 (da) | Sammensætninger af forbindelser og anvendelser deraf | |
DK3532499T3 (da) | ANTI-IL-33-antistoffer og anvendelser deraf | |
MA39746A (fr) | Compositions de sécrétion de polypeptides hétérologues et procédés associés | |
DK2924093T3 (da) | Multicarboxylat-sammensætninger og fremgangsmåde til fremstilling af disse | |
DK3402821T3 (da) | Psma-bindende antistof og anvendelser deraf | |
DK3464456T3 (da) | Hængslet komponent omfattende polyethylensammensætning | |
DK3528902T3 (da) | Ringegelsammensætning | |
ES2841649T5 (es) | Composición farmacéutica | |
KR20180084875A (ko) | 정적 혼합기 | |
TWI799393B (zh) | 樹脂組成物 |